As of 2026-10-25, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 112.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 125.63 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is -10.2%.
The range of the Relative Valuation is 89.20 - 136.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 30.3x | 28.6x |
| Forward P/E multiples | 30.2x - 33.5x | 30.9x |
| Fair Price | 89.20 - 136.31 | 112.78 |
| Upside | -29.0% - 8.5% | -10.2% |
| Date | P/E |
| 2026-10-23 | 36.03 |
| 2026-10-22 | 35.72 |
| 2026-10-21 | 35.80 |
| 2026-10-20 | 35.67 |
| 2026-10-19 | 35.13 |
| 2026-10-16 | 34.94 |
| 2026-10-15 | 34.85 |
| 2026-10-14 | 33.50 |
| 2026-10-13 | 31.44 |
| 2026-10-12 | 31.86 |
| 2026-10-09 | 31.67 |
| 2026-10-08 | 31.50 |
| 2026-10-07 | 31.77 |
| 2026-10-06 | 31.47 |
| 2026-10-05 | 31.06 |
| 2026-10-02 | 31.51 |
| 2026-10-01 | 30.67 |
| 2026-09-30 | 31.66 |
| 2026-09-29 | 31.99 |
| 2026-09-28 | 32.37 |
| 2026-09-25 | 32.66 |
| 2026-09-24 | 33.04 |
| 2026-09-23 | 32.25 |
| 2026-09-22 | 33.02 |
| 2026-09-21 | 31.96 |
| 2026-09-18 | 32.25 |
| 2026-09-17 | 31.45 |
| 2026-09-16 | 31.10 |
| 2026-09-15 | 30.47 |
| 2026-09-14 | 30.95 |
| 2026-09-11 | 30.74 |
| 2026-09-10 | 30.69 |
| 2026-09-09 | 30.80 |
| 2026-09-08 | 31.06 |
| 2026-09-04 | 31.60 |
| 2026-09-03 | 31.76 |
| 2026-09-02 | 31.45 |
| 2026-09-01 | 30.89 |
| 2026-08-31 | 30.54 |
| 2026-08-28 | 30.21 |
| 2026-08-27 | 30.66 |
| 2026-08-26 | 30.70 |
| 2026-08-25 | 31.35 |
| 2026-08-24 | 31.16 |
| 2026-08-21 | 31.02 |
| 2026-08-20 | 30.43 |
| 2026-08-19 | 30.86 |
| 2026-08-18 | 30.08 |
| 2026-08-17 | 29.54 |
| 2026-08-14 | 28.29 |